What's Going On With Exascale Labs Stock Monday?
Exascale Labs (NASDAQ: XLAB) trades up 27% premarket. Read about its 111% revenue growth, AI compute deals, and fiscal 2027 outlook.
Stocks · News reference
Exascale Labs Holdings FY EPS $(8.11K) Down From $(5.11 thousand) YoY, Sales $14.823M Up From $7.016M YoY
Exascale Labs Holdings (NASDAQ:XLAB) reported quarterly losses of $(8.11 thousand) per share. This is a 58.78 percent decrease over losses of $(5.11 thousand) per share from the same period last year. The company
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Exascale Labs Sells 12 Nvidia HGX B300 GPU Servers And 36 Months Of It Operation Services To Sunon For $8.2M
On October 9, 2026, Exascale Labs Holdings Inc. (NASDAQ:XLAB, XLABW))), a Delaware corporation (the "Company"), entered into a purchase and sale agreement dated as of October 8, 2026 (the "PSA") with the
Exascale Labs Appoints Jake Carney As CFO; Gildas Bonnier Ceases As Interim CFO Effective Sept 25, 2026
Exascale Labs shares are trading lower after the company reported a year-over-year decrease in its FY EPS results.
Exascale Labs Announces Non-Binding LOI With Compal Electronics To Jointly Develop U.S. 800 VDC GPU Systems Platform; Compal Intends To Acquire Exascale's Portion After Acceptance Testing
Exascale Labs shares are trading lower after the company announced that it has entered into a non-binding memorandum of understanding with EnergyBank.